glp-1 drugs for weight loss Agonists: Using Semaglutide, Tirzepatide, and Orforglipron and Obesity GLP-1 Drugs from the Gray

The study found that local GLP-1-like peptide activity occurs in joint environments

At Abundant Life Healthcare, we incorporate these innovative medications into individualized treatment plans to support our diabetic patients in achieving optimal health outcomes

Although, at first glance, it is easy to overestimate the findings and assume they apply to everyone, this studys participants were a very specific group: older adults with type 2 diabetes

Many patients taking GLP-1 medications are older, vasculopathic, and already carry significant ocular risk factors, said Rishi P

Within the GLP-1 RA + CKD group, eGFR reduced from 50.1 ml/min per 1.73 m 2 to 44.8 ml/min per 1.73 m 2 at 5 years

Lau SL, Muir C, Assur Y, Beach R, Tran B, Bartrop R, et al